Earlier this month, Acumed, announced they acquired a technology from Bluefish Orthopedics which will help them provide a total elbow arthroplasty (TEA) solution to the market....
SI-BONE ($SIBN) announced an additional 510(k) clearance from the FDA for the use of iFuse Bedrock technology in fusion of the sacroiliac (SI) joint during long construct procedures....
While the Apple Watch held the feature role in the study, an overlooked participant was BioTelemetry as they provided cardiac monitoring services to support the Apple Heart Study....
Initially approved in by the FDA in late 2018, BIOTRONIK announced that they are launching their PK Papyrus covered coronary stent system in the US. The stenting system is the first FDA approved device for the treatment of acute coronary artery perforations in almost two decades....
The Orthotaxy surgical robot prototype was acquired by Johnson & Johnson's DePuy Synthes in 2018 and the the company has done a good job keeping the information light up to this point. At the 2019 AAOS Annual Meeting in Las Vegas...
The Rolling Stones recently postponed 17 shows over the next three months in the U.S. and Canada and the reason became more clear last week as it was reported that lead singer, Sir Mick Jagger, underwent successful transcatheter aortic valve replacement (TAVR) surgery....
A number of companies, including TransEnterix, are set to enter the robotic surgery market in the coming years. The market is projected to reach over $20 billion by 2024, but there's this little company named Intuitive Surgical waiting with history and a...
Medtronic announced the results of a retrospective analysis with their HeartWare left-ventricular assist device, showing targeted blood pressure management helped reduce serious strokes in patients who received the HVAD as a destination therapy....
At the time of writing, Silk Road Medical was up over 81% on their first day of trading after raising $120 million in an upsized IPO. The stock is listed on the Nasdaq and opened at $33,15 under the ticker, "SILK."...
AngioDynamic's stock slid in pre-market action after releasing their third quarter earnings this morning. Overall, net sales in the quarter increased 3% year-over-year to $86.3 million with U.S. net sales coming in at $68.3 million, a year-over-year increase of 3.9%....